Pilot of Mailing Buprenorphine

Recruiting Early Phase 1 Interventional Study
Opioid Use Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Other
Participants needed
20 (estimated)
Sponsor
Medical University of South Carolina · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * English-speaking * Diagnosed with OUD and initiated on buprenorphine during hospitalization * Discharging to a South Carolina address with a stable mailbox * Access to phone or computer Exclusion Criteria: * Active psychosis or suicidal ideation * Severe medical o…
Contacts

No contact information available.